Last edition
News about "Kiran Mazumdar-Shaw, Chairperson of Biocon Group"
Biocon Clarifies Media Reports on Possible Biocon Biologics Merger
Biocon has issued a clarification regarding recent media reports suggesting that the company is considering a potential merger of its unlisted subsidiary, Biocon Biologics Ltd. (BBL), along with IPO and share swap options.
Kiran Mazumdar-Shaw, Chairperson Of Biocon Group | 14/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members